← All trials
NCT05108870
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2022
- Primary completion
- Jan 1, 2026
- Completion date
- Jan 1, 2026
- First posted
- Nov 5, 2021
- Last posted
- Nov 5, 2021
- Enrollment
- 98
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of ChicagoLead sponsor
- University of ChicagoOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.